ReviewRheumatic diseases clinics of North America2013
Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.
Review in Rheumatic diseases clinics of North America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 52 citations in OpenAlex.
- Review
- The Expanding Spectrum of Autoinflammatory Diseases.Internal medicine (Tokyo, Japan) · 2023Article
- The type I interferonopathies: 10 years on.Nature reviews. Immunology · 2022Review
- The role of inflammasomes in cutaneous pathology.Postepy dermatologii i alergologii · 2022Review
- A Novel Mutation in the NBD Domain ofFrontiers in immunology · 2021Article
- [Classification of autoinflammatory diseases based on pathophysiological mechanisms].Zeitschrift fur Rheumatologie · 2020Review
- Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG).Rheumatology international · 2020Article
- Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist.JCI insight · 2017Article
- CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature-a rare case with a novel mutation.European journal of pediatrics · 2016Article
- Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases.Seminars in immunopathology · 2015Review
- Constitutive Activation of the Nlrc4 Inflammasome Prevents Hepatic Fibrosis and Promotes Hepatic Regeneration after Partial Hepatectomy.Mediators of inflammation · 2015Article
- Update on ankylosing spondylitis: current concepts in pathogenesis.Current allergy and asthma reports · 2015Review
- An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.Nature genetics · 2014Article
- Activated STING in a vascular and pulmonary syndrome.The New England journal of medicine · 2014Article
- Periodic Fever: A Review on Clinical, Management and Guideline for Iranian Patients - Part II.Iranian journal of pediatrics · 2014Article
- Editorial: interferon-γ: friend or foe in systemic juvenile idiopathic arthritis and adult-onset Still's Disease?Arthritis & rheumatology (Hoboken, N.J.) · 2014Article
- Inflammasomes and dermatology.Anais brasileiros de dermatologiaReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
The pathogenesis of monogenic autoinflammatory diseases converges on the presence of exaggerated immune responses that are triggered through activation of altered pattern recognition receptor (PRR) pathways and result in cytokine/chemokine amplification loops and the inflammatory clinical phenotype seen in autoinflammatory patients. The PRR response can be triggered by accumulation of metabolites, by mutations in sensors leading to their constitutive overactivation, or by mutations in mediator cytokine pathways that lead to amplification and/or inability to downregulate an inflammatory response in hematopoietic and/or nonhematopoietic cells. The study of the pathogenesis of sterile inflammation in patients with autoinflammatory syndromes continues to uncover novel inflammatory pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.